FDA clears Siemens' 2-in-1 medical scanner

Jun 10, 2011

(AP) -- The Food and Drug Administration says it has cleared the first medical imaging device to simultaneously perform two powerful scans used to diagnose a wide variety of diseases and ailments.

The agency says Siemens' Biograph mMR system runs both a positron emission tomography scan, known as a PET scan, and a scan, or MRI scan. The combination is expected to save time and reduce patients' exposure to radiation.

Older devices combine a and computer tomography, which uses high-powered X-ray scans. Siemens' device replaces that technology with the MRI, which does not contain radiation.

MRI scans use magnetic fields to produce detailed images of organs, bones and other internal structures. PET scans work with a radioactive injection to trace blood flow throughout the body.

Explore further: New system targets germs in donated blood plasma

not rated yet
add to favorites email to friend print save as pdf

Related Stories

MRI/PET scanner combo

Mar 07, 2008

Two kinds of body imaging -- positron emission tomography (PET) and magnetic resonance imaging (MRI) -- have been combined for the first time in a single scanner.

New scans improve treatment accuracy

Sep 14, 2006

Australian doctors say they have developed new scans that can that quickly show whether breast cancer cells are responding to therapy.

Recommended for you

New system targets germs in donated blood plasma

23 hours ago

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

India court blocks Bayer generic drug appeal

Dec 13, 2014

An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.